(HealthDay)—More advanced diabetic retinopathy (DR) at first diagnosis is a significant risk factor for developing sustained blindness over two years, according to a study published online Jan. 20 in Diabetes Care.
Charles C. Wykoff, M.D., Ph.D., from the Blanton Eye Institute in Houston, and colleagues evaluated the association between initial DR severity and risk for blindness in patients with newly diagnosed DR with good vision among 53,535 eyes identified in the American Academy of Ophthalmology Intelligent Research in Sight Registry.
The researchers found that during a mean follow-up of 662.5 days, 1.3 percent of eyes developed sustained blindness. Overall, 10.5 percent of eyes had proliferative DR but made up 26.5 percent (180 of 678) of eyes that developed sustained blindness. Compared with eyes with mild DR at baseline, eyes with moderate nonproliferative DR, severe nonproliferative DR, and proliferative DR at baseline were 2.6, 3.6, and 4.0 times more likely, respectively, to develop sustained blindness two years after DR diagnosis. When adjusting for index characteristics and development of ocular conditions during follow-up, eyes with proliferative DR had an increased risk for developing sustained blindness versus eyes with mild nonproliferative DR at baseline (hazard ratio, 2.26).
“Despite public health guidelines designed to increase eye screening in patients with diabetes, patients are still presenting with advanced DR,” the authors write. “The current results support the continued need for improved DR screening, patient education, and care coordination to reduce the burden of diabetes-associated blindness in the United States.”
Several authors disclosed financial ties to the pharmaceutical industry.
Total retinal blood flow lower in diabetic macular edema
Abstract/Full Text (subscription or payment may be required)
Copyright © 2020 HealthDay. All rights reserved.
Sustained blindness risk higher with severe diabetic retinopathy at diagnosis (2021, February 3)
retrieved 3 February 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- What to know about the side effects of the COVID-19 vaccination - March 2, 2021
- Underarm Lump After COVID Shot Is Likely Lymph Swelling, Not Breast Cancer, Experts Say - March 2, 2021
- फीस नहीं देने के कारण परीक्षा से नहीं किया जाएगा वंचित: राज्य मंत्री श्री परमार - March 2, 2021
- WHO expert panel strongly advises against use of hydroxychloroquine to prevent COVID-19 - March 2, 2021
- U.S. Flu Vaccinations Hit New Record High This Season - March 2, 2021
- कोरोना वैक्सीनेशन संबंधी जानकारी देने के लिए पांच अधिकारी नामांकित - March 2, 2021
- Why you still can’t visit unmasked, even if you’re fully vaccinated - March 2, 2021
- Vaccinating Oldest First for COVID Saves the Most Lives: Study - March 2, 2021
- पचोर नगर की जलावर्धन योजना के लिए भूमि आवंटित - March 2, 2021
- States easing virus restrictions despite experts’ warnings - March 2, 2021